Afya Reports Third Quarter 2026 Revenue Growth and Strong Shareholder Returns
Afya (AFYA) reported third-quarter 2026 revenue of 985 million Brazilian reals, representing a 6% year-over-year increase. The company's growth is primarily driven by its core medical education programs, which account for 85% of total revenue and maintain high student occupancy rates. This stability in undergraduate enrollment provides a reliable foundation for long-term cash flow generation. Despite the top-line growth, the company faces a shift in its continuing education segment as physicians increasingly opt for shorter, lower-cost technical courses rather than lengthy specializations. While this increases total student headcount, it exerts downward pressure on revenue per student. To offset these dynamics and reward investors, Afya has utilized its strong operational cash flow to return 459 million Brazilian reals through dividends and share repurchases during the first nine months of 2026.
Tickers: $AFYA
Topics: medical education revenue growth segment analysis shareholder returns